Osteoporosis in men.
作者信息
Szulc Pawel, Kaufman Jean Marc, Orwoll Eric S
机构信息
INSERM UMR 1033, Hôpital Edouard Herriot, University of Lyon, Pavillon F, Place d'Arsonval, 69437 Lyon, France.
出版信息
J Osteoporos. 2012;2012:675984. doi: 10.1155/2012/675984. Epub 2012 Apr 12.
Abstract
摘要
相似文献
1
Osteoporosis in men.男性骨质疏松症
J Osteoporos. 2012;2012:675984. doi: 10.1155/2012/675984. Epub 2012 Apr 12.
2
Epidemiology and pathophysiology of osteoporosis in men.男性骨质疏松症的流行病学与病理生理学
Curr Osteoporos Rep. 2006 Sep;4(3):110-5. doi: 10.1007/s11914-996-0030-5.
3
Osteoporosis in men.男性骨质疏松症
WMJ. 2002;101(4):28-32.
4
Osteoporosis in men: are we ready to diagnose and treat?男性骨质疏松症：我们准备好进行诊断和治疗了吗？
Curr Rheumatol Rep. 2001 Jun;3(3):240-4. doi: 10.1007/s11926-001-0024-3.
5
Men and osteoporosis.男性与骨质疏松症
Aust Fam Physician. 2001 Aug;30(8):781-5.
6
Osteoporosis in men.男性骨质疏松症
Best Pract Res Clin Rheumatol. 2001 Jul;15(3):415-27. doi: 10.1053/berh.2001.0158.
7
The need for increasing awareness of osteoporosis in men.提高男性对骨质疏松症认识的必要性。
Clin Cornerstone. 2006;8 Suppl 3:S7-13. doi: 10.1016/s1098-3597(06)80018-9.
8
[Risk factors for osteoporosis in men from the Fujiwara-kyo Osteoporosis Risk in Men study].
Clin Calcium. 2016 Jul;26(7):1031-7.
9
Relationships between serum Omentin-1 levels and bone mineral density in older men with osteoporosis.老年骨质疏松男性血清网膜素-1水平与骨密度的关系
Chronic Dis Transl Med. 2016 Apr 6;2(1):48-54. doi: 10.1016/j.cdtm.2016.02.003. eCollection 2016 Mar.
10
Osteoporosis: a disease in men.骨质疏松症：男性中的一种疾病。
Clin Orthop Relat Res. 2004 Aug(425):143-51.
引用本文的文献
1
Gender health gap pre- and post-joint arthroplasty: identifying affected patient-reported health domains.关节置换术前和术后的性别健康差距：确定受影响的患者报告的健康领域。
Int J Equity Health. 2024 Feb 27;23(1):44. doi: 10.1186/s12939-024-02131-5.
2
Making a Move on the Mark of Osteoporosis in Men.关注男性骨质疏松症指标的进展
Gerontol Geriatr Med. 2023 Oct 5;9:23337214231204729. doi: 10.1177/23337214231204729. eCollection 2023 Jan-Dec.
3
Osteoporosis prevention and osteoporosis exercise in community-based public health programs.社区公共卫生项目中的骨质疏松症预防与骨质疏松症运动
Osteoporos Sarcopenia. 2017 Mar;3(1):18-31. doi: 10.1016/j.afos.2016.11.004. Epub 2016 Dec 24.
4
Osteoporosis-preventive behaviors and their promotion for young men.预防骨质疏松的行为及其对年轻男性的推广。
Bonekey Rep. 2015 Aug 5;4:729. doi: 10.1038/bonekey.2015.98. eCollection 2015.
5
Secondary prevention of osteoporosis in non-neck of femur fragility fractures: is it value for money? A retrospective, prospective and cross-sectional cohort study.非股骨颈脆性骨折的骨质疏松症二级预防：是否物有所值？一项回顾性、前瞻性和横断面队列研究。
J Orthop Surg Res. 2013 Dec 1;8:44. doi: 10.1186/1749-799X-8-44.
6
Idiopathic osteoporosis in men.男性特发性骨质疏松症。
Curr Osteoporos Rep. 2013 Dec;11(4):286-98. doi: 10.1007/s11914-013-0164-1.
7
Milk consumption throughout life and bone mineral content and density in elderly men and women.终身牛奶摄入量与老年男性和女性的骨矿物质含量及密度
Osteoporos Int. 2014 Feb;25(2):663-72. doi: 10.1007/s00198-013-2476-5. Epub 2013 Aug 16.
8
Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions.静脉注射唑来膦酸治疗男性骨质疏松症的临床经验：证据与观点。
Ther Adv Musculoskelet Dis. 2013 Aug;5(4):182-98. doi: 10.1177/1759720X13485829.
9
Cost and management of males with closed fractures.男性闭合性骨折的成本与管理。
Osteoporos Int. 2013 Mar;24(3):825-33. doi: 10.1007/s00198-012-2067-x. Epub 2012 Jul 10.
本文引用的文献
1
Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans.基于 CT 扫描的有限元分析预测老年男性新的临床椎体骨折。
J Bone Miner Res. 2012 Apr;27(4):808-16. doi: 10.1002/jbmr.1539.
2
Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancer.他莫昔芬可降低 80 岁以下接受雄激素剥夺治疗前列腺癌的男性的椎体骨折风险。
J Urol. 2011 Dec;186(6):2239-44. doi: 10.1016/j.juro.2011.07.090. Epub 2011 Oct 19.
3
Cross-sectional analysis of the association between fragility fractures and bone microarchitecture in older men: the STRAMBO study.老年男性脆性骨折与骨微结构相关性的横断面分析：STRAMBO 研究。
J Bone Miner Res. 2011 Jun;26(6):1358-67. doi: 10.1002/jbmr.319.
4
Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study.血清 IGF-1 水平低的老年男性发生骨折的风险增加：MrOS 瑞典研究。
J Bone Miner Res. 2011 Apr;26(4):865-72. doi: 10.1002/jbmr.281.
5
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.加拿大 FRAX®工具的骨折预测和校准：来自 CaMos 的基于人群的报告。
Osteoporos Int. 2011 Mar;22(3):829-37. doi: 10.1007/s00198-010-1465-1. Epub 2010 Dec 16.
6
Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men.血清成纤维细胞生长因子 23（FGF-23）与老年男性骨折风险。
J Bone Miner Res. 2011 Apr;26(4):857-64. doi: 10.1002/jbmr.263.
7
Risk factors for peripheral fractures vary by age in older men--the prospective MINOS study.老年男性外周骨折的风险因素因年龄而异——前瞻性 MINOS 研究。
Osteoporos Int. 2011 Jun;22(6):1755-64. doi: 10.1007/s00198-010-1386-z. Epub 2010 Sep 14.
8
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.托瑞米芬降低接受雄激素剥夺治疗的前列腺癌男性骨折风险。
J Urol. 2010 Oct;184(4):1316-21. doi: 10.1016/j.juro.2010.06.022. Epub 2010 Aug 17.
9
Change in hip fracture incidence over the last 6 years in France.法国过去 6 年髋部骨折发病率的变化。
Osteoporos Int. 2011 Mar;22(3):797-801. doi: 10.1007/s00198-010-1255-9. Epub 2010 Jun 2.
10
Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study.唑来膦酸 5mg 每年静脉输注 1 次与每周口服 70mg 阿仑膦酸钠治疗男性骨质疏松症的疗效和安全性：一项随机、多中心、双盲、阳性药物对照研究。
J Bone Miner Res. 2010 Oct;25(10):2239-50. doi: 10.1002/jbmr.119.
Zotero 插件